The National Center for Infectious and Parasitic Diseases (NCIPD) reports that 332 clinical samples with SARS-CoV-2 collected from 06 July – 23 August 2022 were analyzed by next-generation whole-genome sequencing. The clinical samples were collected in 37 different medical centers, from 24 districts of the country.

In all 332 clinical samples, the Omicron variant was identified. The Omicron subvariant ratio was as follows: BA.2.х (1,8%), BA.4.x (3,0%), BA.5.x (72,3%) and BE.x/BF.x, which are a subvariant of BA.5 (22,9%).

Pangolin COVID-19 Lineage Assigner v4.1.1. program was used to define SARS-CoV-2 variants. An epidemiological analysis is being carried out.

For information on the classification of SARS-CoV-2 variants and sub-variants, please visit: https://cov-lineages.org/index.html
For an up-to-date classification of the variants of concern (VOC), please visit:
https://www.ecdc.europa.eu/en/covid-19/variants-concern
https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/

The NCIPD continues to monitor the spread of SARS-CoV-2 in the country, with a focus on VOC, altered virulence and immunogenicity that are of increased public health importance.